RESEARCH DRUG-RELATED PROBLEMS (DRP) IN OUTPATIENT PRESCRIPTION IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION AT CA MAU GENERAL HOSPITAL IN 2024
Main Article Content
Abstract
Background: The use of medications in diabetic patients with concomitant hypertension often results in the occurrence of drug-related problems (DRP), which have been identified as a major cause of treatment failure. The analysis of DRP is a critical function of clinical pharmacy practice in the Faculty of Pharmacy, in accordance with Decision No. 3547/QĐ-BYT issued by the Ministry of Health. However, there remains a lack of comprehensive studies on DRP in diabetic patients with hypertension in Vietnam. Objectives: Investigate patient characteristics and outpatient health insurance prescriptions and identify factors associated with drug-related problems in patients with type 2 diabetes and hypertension at a general hospital in Ca Mau province in 2024. Materials and methods: Cross-sectional descriptive study of drug-related issues according to the guidance of Decision 3547/QD-BYT of the Ministry of Health on prescription information of type 2 diabetes patients with hypertension examined and treated at a general hospital in Ca Mau province. Results: Among the 350 outpatient prescriptions analyzed, the mean patient age was 67.15 ± 13.21 years, 60.3% were women, and the average number of medications per prescription was 6.35 ± 1.43. Overall, 44.6% of the prescriptions contained at least one drug-related problem. Statistically significant differences in DRP occurrence were observed according to the number of medications used. Conclusion: The notably high prevalence of DRP in prescriptions for patients with type 2 diabetes and coexisting hypertension underscores the imperative for strengthened clinical pharmacy monitoring and intervention to enhance treatment safety and efficacy.
Keywords
Drug related problems, DRP, hypertension, diabetes
Article Details
References
2. Abeer Mohammad, Mousa Abujbara, Jafar Alshraideh, Hashem Jaddou, Kamel Ajlouni. The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics. J Endocrinol Metab. 2017. 7(5), 153-158, https://doi.org/10.14740/jem448e
3. Ahlam Bani Salameh, Dana Hyassat, Ahmad Suhail, Zaina Makahleh, Yousef Khader, Mohammed EL-Khateeb, et al. The prevalence of hypertension and its progression among patients with type 2 diabetes in Jordan. Annals of Medicine & Surgery. 2022. 73, https://doi.org/10.1016/j.amsu.2021.103162.
4. Bộ Y tế (2021), Quyết định 3547/QĐ-BYT năm 2021 quy định về mẫu phân tích thuốc và các vấn đề liên quan đến thuốc.
5. Quách Ngọc Dung, Dương Xuân Chữ, Võ Minh Phương. Đặc điểm kê đơn thuốc và các vấn đề bất lợi liên quan đến thuốc trong đơn thuốc ngoại trú cho bệnh nhân đái tháo đường và tăng huyết áp tại bệnh viện đa khoa bạc liêu, Tạp chí Y Dược học Cần Thơ. 2021. 39, pp 23-29, https://tapchi.ctump.edu.vn/index.php/ctump/article/view/834.
6. Bùi Minh Thiện, Dương Xuân Chữ. Một số vấn đề liên quan đến thuốc trong kê đơn điều trị ngoại trú trên bệnh nhân cao tuổi tại Trung tâm y tế Trà Cú, tỉnh Trà Vinh năm 2022, Tạp chí Y Dược học Cần Thơ. 2023. 61, 50-56, https://doi.org/10.58490/ctump.2023i61.1252.
7. Kefale B., Tegegne G. T., Kefale Y., Molla M., Ewunetei A., & Degu A. Magnitude and determinants of drug therapy problems among typee 2 diabetes mellitus patients with hypertension in Ethiopia, SAGE Open Medicine. 2020. 8, pp. 1–8, https://doi.org/10.1177/2050312120954695.
8. Osoro I., Amir M., Vohra M., & Sharma A. Pharmacist Interventions in Minimizing Drug Related Problems in Diabetes With Co-Existing Hypertension: A Five-Year Overview and Ground Report From India, International Journal of Public Health. 2023. 68, pp. 1605808, https://doi.org/10.3389/ijph.2023.1605808.
9. American Diabetes Association (ADA) (2024) "Standard of medical care in diabetes".
10. Mechessa D. F. & Kebede B. Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital,
Southwest Ethiopia, Diabetes Metabolic Syndrome and Obesity. 2020. 13, pp. 3349–3357, https://doi.org/10.2147/DMSO.S267790.
11. Kusumawardani L. A., Andrajati R. & Nusaibah A. Drug-related problems in hypertensive patients: a cross-sectional study from Indonesia, J Res Pharm Pract. 2020. 9(3), 140–145, https://doi.org/10.4103/jrpp.JRPP_20_16.